{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-024758","form_type":"8-K","ticker":"USAQ","cik":"0000856984","company_name":"QHSLab, Inc.","filed_at":"2025-11-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.373100+00:00","generated_at":"2026-05-16T17:29:08.681507+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"QHSLab nine-month revenue $1.99M; retires convertible notes, eliminates dilution overhang","bullets":["Nine-month 2025 revenue $1.99M, up 32% YoY from $1.51M; gross profit $1.32M.","Unaudited October revenue ~$285k, implying annualized run rate over $3.4M.","Retired two overdue convertible notes (18% interest, $0.20 conversion) removing over $1.4M in liabilities.","DTC float only 2,429,525 shares; structural dilution risk eliminated.","Company expects strong momentum into 2026, focusing on scaling digital-health revenues."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-024758","json":"https://secwatch.observer/filing/0001493152-25-024758.json","markdown":"https://secwatch.observer/filing/0001493152-25-024758.md","text":"https://secwatch.observer/filing/0001493152-25-024758.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856984/000149315225024758/0001493152-25-024758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856984/000149315225024758/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:29:08.681507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}